| 5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in … S Pastore, G Stocco, V Moressa, L Zandonà, D Favretto, N Malusà, ... Rheumatology International 35, 619-627, 2015 | 19 | 2015 |
| 5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in … S Pastore, G Stocco, V Moressa, C Sandrin, G Decorti, L Lepore, A Taddio Pediatric Rheumatology 12, 1-1, 2014 | 4 | 2014 |
| A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity SH Chen, W Yang, Y Fan, G Stocco, KR Crews, JJ Yang, SW Paugh, ... Leukemia 25 (1), 66-74, 2011 | 59 | 2011 |
| A Genome-Wide Approach Identifies Variations in the Aspartate Metabolism Pathway That Are Associated with Asparaginase Sensitivity SH Chen, W Yang, Y Fang, G Stocco, KR Crews, CH Pui, WE Evans, ... Blood 112 (11), 213, 2008 | | 2008 |
| A new proof of evidence of cysteamine quantification for therapeutic drug monitoring in patients with cystinosis M Franzin, S Rossetto, R Ruoso, R Del Savio, G Stocco, G Decorti, ... Orphanet Journal of Rare Diseases 17 (1), 400, 2022 | 2 | 2022 |
| A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias O Montecchini, S Braidotti, R Franca, G Zudeh, C Boni, C Sorio, ... Frontiers in Pharmacology 12, 749361, 2021 | 5 | 2021 |
| A novel peptide biosensor for screening ABL1 activity in vitro: a challenge for precision therapy in BCR-ABL1 and BCR-ABL1 like leukemias. O Montecchini, S Braidotti, R Franca, G Zudeh, C Boni, C Sorio, ... Authorea Preprints, 2024 | | 2024 |
| A patent review of anticancer glucocorticoid receptor modulators (2014-present) M Lucafò, M Franzin, G Decorti, G Stocco Expert Opinion on Therapeutic Patents 30 (5), 313-324, 2020 | 5 | 2020 |
| A validated HPLC–diode array detection method for therapeutic drug monitoring of thiopurines in pediatric patients: From bench to bedside M Franzin, D Curci, M Lucafò, M Bramuzzo, M Rabusin, A Fabretto, ... Metabolites 12 (12), 1173, 2022 | 2 | 2022 |
| ABCB1 and ABCC1 variants associated with virological failure of first‐line protease inhibitors antiretroviral regimens in Northeast Brazil patients AVC Coelho, SPS Silva, LCA de Alencar, G Stocco, S Crovella, ... The Journal of Clinical Pharmacology 53 (12), 1286-1293, 2013 | 36 | 2013 |
| ABCB1 gene polymorphisms and expression of P-glycoprotein and long-term prognosis in colorectal cancer S De Iudicibus, A De Pellegrin, G Stocco, F Bartoli, R Bussani, G Decorti Anticancer research 28 (6B), 3921-3928, 2008 | 43 | 2008 |
| Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease S De Iudicibus, G Stocco, S Martelossi, I Drigo, S Norbedo, P Lionetti, ... Gut 56 (9), 1319-1320, 2007 | 83 | 2007 |
| Atomic force microscopy application for the measurement of infliximab concentration in healthy donors and pediatric patients with inflammatory bowel disease D Curci, M Lucafò, P Parisse, G Decorti, M Bramuzzo, L Casalis, G Stocco Journal of Personalized Medicine 12 (6), 948, 2022 | 3 | 2022 |
| Azathioprine biotransformation in young patients with inflammatory bowel disease: contribution of glutathione-S transferase M1 and A1 variants M Lucafò, G Stocco, S Martelossi, D Favretto, R Franca, N Malusà, A Lora, ... Genes 10 (4), 277, 2019 | 16 | 2019 |
| Azathioprine pharmacokinetics in early onset inflammatory bowel disease G Stocco, S Martelossi, S De Iudicibus, D Favretto, E Cuzzoni, R Franca, ... Digestive and Liver Disease 46, e77-e78, 2014 | | 2014 |
| Azathioprine/mesalazine interaction G Stocco Reactions 1230, 29, 2008 | | 2008 |
| BIOMARKERS AND PRECISION THERAPY FOR PRIMARY IMMUNODEFICIENCIES: AN EX VIVO STUDY IN INDUCIBLE PLURIPOTENT STEM CELLS FROM PATIENTS. E Genova, F Cavion, M Lucafo, M Pelin, A Tesser, E Piscianz, G Lanzi, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 105, S72-S73, 2019 | | 2019 |
| Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients E Genova, F Cavion, M Lucafò, M Pelin, G Lanzi, S Masneri, RM Ferraro, ... Clinical Pharmacology & Therapeutics 108 (2), 358-367, 2020 | 10 | 2020 |
| Biomarkers for gastrointestinal adverse events related to thiopurine therapy G Zudeh, R Franca, G Stocco, G Decorti World Journal of Gastroenterology 27 (38), 6348, 2021 | 2 | 2021 |
| BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress L Cesaratto, E Grisard, M Coan, L Zandonà, E De Mattia, E Poletto, ... Cell death & disease 7 (9), e2374-e2374, 2016 | 35 | 2016 |
Alessandro VenturaIRCCS Burlo Garofolo, Trieste; Università di Trieste; Università di Pisa在 burlo.trieste.it 的电子邮件经过验证
